Ann: Presentation to highlight broader potential of Deoxymabs, page-60

Well Duke i am glad my thoughts are aligned more so with the Dr's than yours..

Looking at the possibilties for our IP's is very exciting as partnerships/deals is what the Dr is looking for to co/develop.
Looking forward after the GMP is a success brings many more possibilties to PAB's table, if you think that PAB moving forward after DX-1 human trials is all that we are about then take the blinkers off, because we are not a one trick pony..

The Dr has elluded to partnerships for years, GMP has stalled everything, when GMP is successful then it all comes back into play..

We are at 1c for a reason right now and the Dr is going to add multiples of this well before the trials, do investors with your thought process wait for the PH 1 trials and get in at way over where we are now or do believers and people who listen to the Dr jump in to where the real value is?